Objective: This study aimed to determine the significance of the venous drainage pattern of bronchopulmonary sequestration (BPS) in the prenatal course. Methods: The venous drainage pattern of fetuses with BPS was determined with high-definition flow and confirmed by postnatal three-dimensional computed tomography angiography scan or autopsy. The volume of BPS lesions during gestation was recorded by the three-dimensional ultrasonographic Virtual Organ Computer-Aided Analysis software. The relationship between venous drainage pattern and prenatal characteristics was determined. Results: Seventy-one fetuses were enrolled: 35 with systemic venous drainage (SVD) and 36 with pulmonary venous drainage (PVD). The volumes of BPS lesions significantly increased from the middle second trimester to the later second trimester in the SVD group. A marked decrease from the later second trimester to the third trimester was observed in the PVD group. The incidences of associated anomalies, hydrops, and polyhydramnios in the SVD group were 14.2, 23.3, and 33.3%, respectively, significantly higher than those in the PVD group (0, 0, and 5.6%, respectively). Conclusions: Our data indicate that SVD is correlated with a higher risk of associated anomalies and an unfavorable prenatal course in fetal BPS. Identification of the venous drainage pattern is of clinical significance in predicting the prenatal behavior of fetal BPS.

1.
Stocker JT: Sequestrations of the lung. Semin Diagn Pathol 1986; 3: 106–121.
2.
Pryce DM: Lower accessory pulmonary artery with intralobar sequestration of lung; a report of seven cases. J Pathol Bacteriol 1946; 58: 457–467.
3.
Xie HN, Li LJ, He H, Shi HJ, Peng R, Zhu YX: Prenatal surveillance of bronchopulmonary sequestration using 3-dimensional ultrasonography. J Ultrasound Med 2009; 28: 989–994.
4.
Mallmann MR, Geipel A, Bludau M, Matil K, Gottschalk I, Hoopmann M, Muller A, Bachour H, Heydweiller A, Gembruch U, Berg C: Bronchopulmonary sequestration with massive pleural effusion: pleuroamniotic shunting vs intrafetal vascular laser ablation. Ultrasound Obstet Gynecol 2014; 44: 441–446.
5.
Lopoo JB, Goldstein RB, Lipshutz GS, Goldberg JD, Harrison MR, Albanese CT: Fetal pulmonary sequestration: a favorable congenital lung lesion. Obstet Gynecol 1999; 94: 567–571.
6.
Brus F, Nikkels PG, van Loon AJ, Okken A: Non-immune hydrops fetalis and bilateral pulmonary hypoplasia in a newborn infant with extralobar pulmonary sequestration. Acta Paediatr 1993; 82: 416–418.
7.
Kitano Y, Sago H, Hayashi S, Kuroda T, Honna T, Morikawa N: Aberrant venous flow measurement may predict the clinical behavior of a fetal extralobar pulmonary sequestration. Fetal Diagn Ther 2008; 23: 299–302.
8.
Kitano Y, Matsuoka K, Honna T, Kuroda T, Morikawa N, Hayashi S, Sago H: Venous arterialization in extralobar pulmonary sequestration associated with fetal hydrops. J Pediatr Surg 2006; 41: 490–494.
9.
Zhang H, Tian J, Chen Z, Ma X, Yu G, Zhang J, Jiang G, Wang L: Retrospective study of prenatal diagnosed pulmonary sequestration. Pediatr Surg Int 2014; 30: 47–53.
10.
Kim SH, Lee JM, Kim YJ, Lee JY, Han JK, Choi BI: High-definition flow Doppler ultrasonographic technique to assess hepatic vasculature compared with color or power Doppler ultrasonography: preliminary experience. J Ultrasound Med 2008; 27: 1491–1501.
11.
Allan LD, Cook AC, Huggon IC: Fetal Echocardiography: A Practical Guide. New York, Cambridge University Press, 2009.
12.
Crombleholme TM, Coleman B, Hedrick H, Liechty K, Howell L, Flake AW, Johnson M, Adzick NS: Cystic adenomatoid malformation volume ratio predicts outcome in prenatally diagnosed cystic adenomatoid malformation of the lung. J Pediatr Surg 2002; 37: 331–338.
13.
Corbett HJ, Humphrey GM: Pulmonary sequestration. Paediatr Respir Rev 2004; 5: 59–68.
14.
Grethel EJ, Farrell J, Ball RH, Keller RL, Goldstein RB, Lee H, Farmer DL, Harrison MR, Nobuhara KK: Does congenital diaphragmatic hernia associated with bronchopulmonary sequestration portend a better prognosis? Fetal Diagn Ther 2008; 23: 250–253.
15.
Andrade CF, Ferreira HP, Fischer GB: Congenital lung malformations. J Bras Pneumol 2011; 37: 259–271.
16.
Sepulveda W: Perinatal imaging in bronchopulmonary sequestration. J Ultrasound Med 2009; 28: 89–94.
17.
Yue SW, Guo H, Zhang YG, Gao JB, Ma XX, Ding PX: The clinical value of computer tomographic angiography for the diagnosis and therapeutic planning of patients with pulmonary sequestration. Eur J Cardiothorac Surg 2013; 43: 946–951.
18.
Wei Y, Li F: Pulmonary sequestration: a retrospective analysis of 2625 cases in China. Eur J Cardiothorac Surg 2011; 40:e39–e42.
19.
Hernanz-Schulman M, Stein SM, Neblett WW, Atkinson JB, Kirchner SG, Heller RM, Merrill WH, Fleischer AC: Pulmonary sequestration: diagnosis with color Doppler sonography and a new theory of associat ed hydrothorax. Radiology 1991; 180: 817– 821.
20.
Rodgers BM, Harman PK, Johnson AM: Bronchopulmonary foregut malformations. The spectrum of anomalies. Ann Surg 1986; 203: 517–524.
21.
Ruano R, Ramalho AS, de Freitas RC, Campos JA, Lee W, Zugaib M: Three-dimensional ultrasonographic assessment of fetal total lung volume as a prognostic factor in primary pleural effusion. J Ultrasound Med 2012; 31: 1731–1739.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.